1Ferro JM,Canhao P, Stare J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke, 2004, 35:664 -670.
2Sepulveda JM, Posada IJ, Gonzalez de la Aleja J, et al. Anticoagulant treatment in hemorrhagic brains infarts due to large sinus venous thrombosis. Neurologia, 2004, 19:769 - 773.
3Soleau SW, Schmidt R,Stevens S, et al. Extensive experience with dural sinus thrombosis. Neurosurgery, 2003, 52:534 - 544.
4de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecule-weight heparin for cerebral sinus thrombosis. Stroke, 1999, 30:484 -488.
5Masubr F, Mehraein S, Einhaupl K. Cerebral venous and sinus thrombosis. J Neurol, 2004, 251 : 11 - 23.
6van Nuenen BF, Munneke M, Bloem BR. Cerebral venous sinus thrombosis: prevention of recurrent thromboembolism. Stroke, 2005, 36:1822 - 1823.
7Turpie AG. State of the art-a journey through the world of antithrombotic therapy. Semin Thromb Hemost, 2002, 28: 3 - 11.
8Masuhr F, Mehraein S. Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment. Neurocrit Care, 2004, 1:355 -361.
9Perkin GD. Cerebral wnous thrombosis: medical therapy. J R Soc Med, 2000, 93 : 238 - 240.
10Canhao P, Falcao F, Ferro JM.Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis, 2003, 15:159 - 166.
